Rating of tumoral growth in non-operated primary or recurrent extra-abdominal aggressive fibromatosis;Étude de la croissance tumorale des tumeurs desmoïdes extra-abdominales (FDEA) primitives ou récidivées non opérées

Revue de Chirurgie Orthopedique et Reparatrice de l'Appareil Moteur

Volumn 93, Issue 6, 2007, Pages 546-554

  Gouin, F ^a   Tesson, A ^a   Bertrand Vasseur, A ^a   Cassagnau, E ^a   Rolland, F ^b  

^a HÔTEL DIEU   (France)

^b Service d'Oncologie Médicale   (France)

Author keywords

Aggressive fibromatosis; Soft tissue; Tumor

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; CANCER INVASION; COHORT ANALYSIS; DISEASE COURSE; FEMALE; FIBROMATOSIS; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PATHOLOGY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; REMISSION; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FIBROMATOSIS, AGGRESSIVE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 36849000311     PISSN: 00351040     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-1040(07)92676-8     Document Type: Article

References (30)

1. ALMAN BA, PAJERSKI ME, DIAZ-CANO S, CORBOY K, WOLFE HJ : Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol, 1997, 6, 98-101.
2. LI M, CORDON-CARDO C, GERALD WL, ROSAL J : Desmoid fibromatosis is a clonal process. Hum Pathol, 1996, 27, 939-943.
3. CHEW C, REID R, O'DWYER PJ : Evaluation of the long term outcome of patients with extremity desmoids. Eur J Surg, 2004, 30, 428-432.
4. DUGGAL A, DICKINSON IC, SOMMERVILLE S, GALLIE P : The management of extra-abdominal desmoid tumours. Int Orthop, 2004, 28, 252-256.
5. GRONCHI A, CASALI PG, MARIANI L, LO VULLO S, COLECCHIA M, LOZZA L et al. : Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol, 2003, 21, 1390-1397.
6. LEWIS JJ, BOLAND PJ, LEUNG DHY, WOODRUFF JM, BRENNAN MF : The enigma of desmoid tumors. Annals of Surgery, 1999, 229, 866-873.
7. MCCOLLOUGH W, PARSONS J, VAN DER GRIEND R, ENNEKING W, HEARE T : Radiotherapy fo aggressive fibromatosis: the experience of the University of Florida. J Bone Joint Surg (Am), 1991, 73, 717-725.
8. PIGNATTI G, BARBANTI-BRODANO G, FERRARI D, GHERLINZONI F, BERTONI F, BACCHINI P et al. : Extra-abdominal desmoid tumor. Clin Orthop, 2000, 375, 207-213.
9. PRITCHARD DJ, NASCIMENTO AG, PETERSEN IA : Local control of extra-abdominal desmoid tumors. J Bone Joint Surg (Am), 1996, 78-A, 848-854.
10. REITAMO JJ, SCHEININ TM, HAYRY P : The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am J Surg, 1986, 151, 230-237.
11. ROCK MG, PRITCHARD DJ, REIMAN HM, SOULE EH, BREWSTER RC : Extra-abdominal desmoid tumors. J Bone Joint Surg (Am), 1984, 66-A, 1369-1374.
12. SORENSEN A, KELLER J, NIELSEN OS, JENSEN OM : Treatment of aggressive fibromatosis. A retrospective study of 72 patients followed for 1-27 years. Acta Orthop Scand, 2002, 73, 213-219.
13. AYADI K, TRIGUI M, ZRIBI M, KALLEL MH, KHANNOUS M, TRIKI FE et al. : Traitement chirurgical des tumeurs desmoïdes extra-abdominales. A propos de 12 cas. Rev Chir Orthop, 2003, 89, 385-392.
14. CHATELARD PA, GILLY FN, CARRET JP, WAUZELLE JL, BRUNAT M, BRAILLON G, DEJOUR H : Tumeurs desmoïdes extra-abdominales, indications thérapeutiques à propos de 28 cas. Acta Orthop Belg, 1991, 57, 227-233.
15. DALEN BP, BERG PM, GUNTERBERG BU : Desmoid tumors: a clinical review of 30 patients with more than 20 years' follow-up. Acta Orthop Scand, 2003, 74, 455-459.
16. JENKINS NH, FREEDAMN LS, MCKIBBIN B : Spontaneous regression of a desmoid tumour. J Bone Joint Surg (Br), 1986, 68-B, 780-781.
17. MEARY R, SANAN JP, TOMÉNO B, FOREST M, CIROTTEAU Y : Fibromes desmoïdes des membres. Rev Chir Orthop, 1978, 64, 195-204.
18. EASTER DW, HALASZ NA : Recent trends in the management of desmoid tumors. Ann Surg, 1989, 210, 765-769.
19. MERCHANT NB, LEWIS JJ, WOODRUFF JM, LEUNG SHY, BRENNAN MF : Extremity and trunk desmoid tumors. A multifactorial analysis of outcome. Cancer, 1999, 86, 2045-2052.
20. ENNEKING WF, SPANIER SS, GOODMAN MA : A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop, 1980, 153, 106-120.
21. LEITHNER A, GAPP M, LEITHNER K, RADL R, KRIPPL P, BEHAM A et al : Margins in extra-abdominal desmoid tumors: a comparative analysis. J Surg Oncol, 2004, 86, 152-156.
22. NUYTTENS JJ, RUST PF, THOMAS CR Jr, TURRISI AT : Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer, 2000, 88, 1517-1523.
23. KARAKOUSI CP, MAYORDOMO J, ZOGRAFOS GC, DIRSCOLL DL : Desmoid tumors of the trunk an extremity. Cancer, 1993, 72, 1637-1641.
24. KINZBRUNNER B, RITTER S, DOMINGO J, ROSENTHAL CJ : Remission of rapidly growing desmoid tumors after tamoxifen therapy. Cancer, 1983, 15, 2201-2205.
25. SPORTIELLO DJ, HOOGERLAND DL. A recurrent pelvic desmoid tumor successfully treated with tamoxifen. Cancer, 1991, 67, 1443-1449.
26. LACKNER H, URBAN C, KERBL R, SCHWINGER W, BEHAM A : noncytotoxic drug therapy in children with unresectable desmoid tumors. Cancer, 1997, 80, 334-340.
27. WADDELL WR, KIRSCH WM : testolactone, sulindac, warfarin and vitamin K1 for unresectable desmoid tumors. Am J Surg, 1991, 161, 416-421.
28. POON R, SMITS R, LI C, JAGMOHAN- CHANGUR S, KONG M, CHEON S et al. : Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene, 2001, 25, 451-460.
29. BALISKI CR, TEMPLE WJ, ARTHUR K, SCHACHAR NS : Desmoid tumors: a novel approach for local control. J Surg Oncol, 2002, 80, 96-99.
30. AZZARELLI A, GRONCHI A, BERTULLI R, TESORO JD, BARATTI D, PENNACCHIOLI E et al. : Low-dose chemotherapy with methotrexate and vinblatine for patients with advanced aggressive fibromatosis. Cancer, 2001, 92, 1259-1264.